ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
0.788
0.006
(0.77%)
Closed November 23 10:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.788
Bid
0.781
Ask
0.788
Volume
14,944
0.78 Day's Range 0.80
0.76 52 Week Range 1.52
Market Cap
Previous Close
0.782
Open
0.79
Last Trade
1
@
0.788
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
34,859
Shares Outstanding
100,852,742
Dividend Yield
-
PE Ratio
-3.57
Earnings Per Share (EPS)
-0.22
Revenue
7.9M
Net Profit
-22.33M

About Transgene SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Illkirch-graffenstaden, Bas-rhin, Fra
Founded
-
Transgene SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker TNG. The last closing price for Transgene was 0.78 €. Over the last year, Transgene shares have traded in a share price range of 0.76 € to 1.52 €.

Transgene currently has 100,852,742 shares outstanding. The market capitalization of Transgene is 78.87 € million. Transgene has a price to earnings ratio (PE ratio) of -3.57.

TNG Latest News

Transgene et NEC présentent de nouvelles données confirmant la preuve de principe clinique pour son vaccin thérapeutique TG4050, dans les cancers de la tête et du cou au SITC 2024

Transgene et NEC présentent de nouvelles données confirmant la preuve de principe clinique pour son vaccin thérapeutique TG4050, dans les cancers de la tête et du cou au SITC 2024 Les données de...

Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024

Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant standard of care remain disease-free TG4050 induced...

Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024

Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024 Compelling 24.1-month median follow-up data...

Transgene fait le point sur ses activités, son portefeuille et sa situation financière au troisième trimestre 2024

Transgene fait le point sur ses activités, son portefeuille et sa situation financière au troisième trimestre 2024 TG4050 : Données prometteuses de Phase I présentées au SITC 2024 confirmant une...

Transgene Reports Business, Pipeline and Financial Update for Q3 2024

Transgene Reports Business, Pipeline and Financial Update for Q3 2024 TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck...

Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development

Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development Strasbourg (France), Berlin (Germany), November 5, 2024, 7:30 a.m. CET—Transgene (Euronext Paris: TNG), a...

Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development

Strasbourg (France), Berlin (Germany), November 5, 2024, 7:30 a.m. CET—Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of...

Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés

Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés Strasbourg (France), Berlin (Germany), le 5 novembre 2024, 7 h 30 Transgene...

Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers

Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers Top line data show that the randomized...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.05-5.966587112170.8380.8380.76291610.78748416DE
4-0.138-14.90280777540.9260.9640.76405130.86634154DE
12-0.34-30.14184397161.1281.2040.76348590.98604941DE
26-0.536-40.48338368581.3241.350.76300401.05785457DE
52-0.662-45.65517241381.451.520.76297731.17604595DE
156-1.622-67.30290456432.412.990.76380461.92820697DE
260-1.022-56.46408839781.813.150.76743991.98395186DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLAAHAmatheon Agri Holding NV
0.02 €
(100.00%)
5k
GNROGeNeuro SA
0.0768 €
(25.49%)
200
BIDSGascogne DS
0.005 €
(25.00%)
150.51k
ALSAFSAFE
0.11 €
(23.73%)
39.98k
ALKKOKKO International SA
0.112 €
(21.21%)
4.13M
ALIMOGroupimo
0.189 €
(-40.94%)
392
MLUMGUmalis Group
1.30 €
(-31.22%)
1.71k
MLNMAMiguet Et Associes
0.075 €
(-24.62%)
1.72k
MLSEQSequa Petroleum NV
0.008 €
(-20.00%)
23k
VACBSPierre & Vacances
0.05 €
(-15.25%)
35.99k
BCPBanco Comercial Portugues SA
0.4446 €
(-0.49%)
69.24M
ALNEVNeovacs
0.0002 €
(0.00%)
41.4M
ALCYBCybergun
0.0001 €
(0.00%)
30.32M
INGAING Groep NV
14.652 €
(-1.16%)
14.06M
ACACredit Agricole SA
13.05 €
(-1.66%)
8.06M

Discussion

View Full Feed
VoyagerRealm96 VoyagerRealm96 1 minute ago
https://www.barchart.com/stocks/quotes/RDAR/opinion
RDAR
StayHumble StayHumble 2 minutes ago
Yes it is!✅w0w! No r/s+ MERGER AQUISITION ✅✅huzzah!
https://x.com/CorporateUbqu/status/1765510100628726105?s=20
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
UBQU
rogers711 rogers711 2 minutes ago
They did clearly state the IDE is in a great spot right now it's just additional information... they are close in my opinion...
RDGL
MysticalDwarf46 MysticalDwarf46 3 minutes ago
https://lacdmhowr.powerappsportals.us/forums/general-discussion/30c01204-81a9-ef11-b542-001dd8097a1a
The ELTP King The ELTP King 4 minutes ago
Pocket change:

Nasdaq Capital Market
Entry Fee: $75,000, including $5,000 application fee

Nasdaq Global Select Market and Nasdaq Global Market
Entry Fee: $295,000, including $25,000 application fee
How much does it cost to uplist to NASDAQ?
API
StayHumble StayHumble 4 minutes ago
✅🎃wow $50 POSSIBLE with this✅EXPERT info✅https://gncc-capital.com/Highlights.html ✅
GNCP
The ELTP King The ELTP King 4 minutes ago
Well golly gee whiz,

Who's been saying every week that Nasrat needs to uplist to the Nasdaq..........🤔

Nasrat, do what it takes to get us on Nasdaq!
ELTP
The ELTP King The ELTP King 5 minutes ago
The King knew it was coming before November 23.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175401105

One week ago today, many of us thought we'd get the answer/approval from FDA possibly today, Saturday or Monday. Instead, we get approval this past M
ELTP
ElectricJester54 ElectricJester54 5 minutes ago
FWT didn't come online as a possibility until a few weeks back, at least as an actual named entity. He speculated a few times about a few smaller revenue companies coming in but I don't think he names names until he is pretty certain its gonna happen. I do think FWT was part of his most recent PPS p
AZRH
karw karw 5 minutes ago
Hi Tom,

This may lead to better downside averaging of one's cost/share.


While rereading chapter 15 (4th edition) Twinvest, I saw that Mr. Lichello made the same point on page 226 at the bottom:

Your Cost Per Share is only $6.36 ....etc.. describin
StayHumble StayHumble 6 minutes ago
BUY low✅Sell HIGH✅$9.99 a Share huzzah🍀🍀✅✅
MJNA
WebSlinger WebSlinger 8 minutes ago
>

I think that there is a very high probability that NASDAQ will give $SMCI an extension.

$SMCI hired a top 5 accounting firm in BDO, and also filed their compliance plan.
SMCI
JimmyTwoTimes JimmyTwoTimes 9 minutes ago
https://m.youtube.com/watch?v=xVj1YnnZF3o
OWPC
Hicham007 Hicham007 9 minutes ago
Loading back to 120 and hopefully not having to sell the 30 at 12 SP.

 This yo-yo will continue but I hope, and logically speaking, now that we are style="font-size: 1em" commercial stage as GMH noted it will be shifting the yo-yo upward from 8 - 12 to 12 - 16 overtime.
IOVA
MysticalDwarf46 MysticalDwarf46 9 minutes ago
https://lacdmhowr.powerappsportals.us/forums/general-discussion/b0458092-82a9-ef11-b542-001dd8097a1a
titan11 titan11 10 minutes ago
So this is going at $34 pps ipo target? 
CBRS
PEACHMAN PEACHMAN 10 minutes ago
AFTER you click on the link you need to scroll all the way down and look at before and after pictures of how effective Supreme AG mulch is .


https://impactfusionbrands.com/product/supreme-ag/

Instead of asking questions paid bashers can scroll down further and r
IFUS
Curt D Curt D 11 minutes ago
By the trading action in Friday's power hour, we could be seeing updates early next week.
RDAR
MysticalOgre70 MysticalOgre70 12 minutes ago
https://www.yelp.com/biz/breeze-airways-white-plains?hrid=XOxwFfVy3NHE3B82VJF7wQ&utm_campaign=www_review_share_popup&utm_medium=copy_link&utm_source=(direct)
MysticalDwarf46 MysticalDwarf46 13 minutes ago
https://lacdmhowr.powerappsportals.us/forums/general-discussion/6aff5f2a-83a9-ef11-b542-001dd8097a1a
PEACHMAN PEACHMAN 15 minutes ago
Hey uber did you look at the before and after pictures of trees,plants roses,and fruits in your search of the truth?


https://impactfusionbrands.com/product/supreme-ag/

Do you know what lignin is?


Do you know what Supreme AG is?
IFUS
mankind mankind 16 minutes ago
Prolly not, but it's business title is "Quantum". I took 1/3 off @ $1.70, missed the high by a penny. Sector means nothing for my purposes.
MysticalDwarf46 MysticalDwarf46 16 minutes ago
https://lacdmhowr.powerappsportals.us/forums/general-discussion/b3a3e867-83a9-ef11-b542-001dd8097a1a
SamuraiTrailblazer71 SamuraiTrailblazer71 17 minutes ago
https://lacdmhowr.powerappsportals.us/forums/general-discussion/bc7c3990-96a9-ef11-b542-001dd8097a1a

Your Recent History

Delayed Upgrade Clock